Evidence map›Paper›PMID 37623456›Full record

ArticleJournal of personalized medicine2023

Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective.

Asim Rizvi, Sara Faiz, Parin H Thakkar, Syed Hussain, Ann N Gamilla-Crudo, Michael Kueht, Muhammad A Mujtaba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Asim RizviDepartment of Nephrology, Hypertension and Transplant Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.ORCID 0000-0002-7046-4455
Sara FaizDepartment of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
Parin H ThakkarDepartment of Nephrology, Hypertension and Transplant Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.ORCID 0000-0003-2399-6990
Syed HussainDepartment of Nephrology, Hypertension and Transplant Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.
Ann N Gamilla-CrudoDepartment of Nephrology, Hypertension and Transplant Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.
Michael KuehtDepartment of Transplant Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.ORCID 0000-0003-2509-0877
Muhammad A MujtabaDepartment of Nephrology, Hypertension and Transplant Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.ORCID 0000-0001-9426-4290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Donor-derived cell-free DNA (dd-cfDNA) may safely assess kidney allograft rejection. Molecular Microscope (MMDx

Indexed as

antibody-mediated rejectiondonor-derived cell-free DNAdonor-specific antibodyMolecular Microscope Diagnostic System (MMDx®)rejection

Identifiers

PMID37623456
PMCPMC10455393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.